Auletta JJ, Kou J, Chen M, et al. Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023;29(6):346. e1–346. e10.

Ringdén O, Boumendil A, Labopin M, et al. Outcome of allogeneic hematopoietic stem cell transplantation in patients age >69 years with acute myelogenous leukemia: on behalf of the acute leukemia working party of the European society for blood and marrow transplantation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2019;25(10):1975–83. https://doi.org/10.1016/j.bbmt.2019.05.037.

Article  Google Scholar 

Harrison RA, Sharafeldin N, Rexer JL, et al. Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms. Oncologist. 2021;26(11):e2021–33. https://doi.org/10.1002/onco.13867.

Article  PubMed  PubMed Central  Google Scholar 

Kelly DL, Buchbinder D, Duarte RF, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and quality of life working committee of the center for international blood and marrow transplant research and complications and quality of life working party of the European society for blood and marrow transplantation. Biol Blood Marrow Transplant. 2018;24(2):228–41.

Article  PubMed  Google Scholar 

Hshieh TT, Jung WF, Grande LJ, et al. Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncol. 2018;4(5):686–93. https://doi.org/10.1001/jamaoncol.2017.5674.

Article  PubMed  PubMed Central  Google Scholar 

Olin RL, Fretham C, Pasquini MC, et al. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Adv. 2020;4(12):2810–20. https://doi.org/10.1182/bloodadvances.2020001719.

Article  PubMed  PubMed Central  Google Scholar 

Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 2002;95(1):183–92. https://doi.org/10.1002/cncr.10627.

Article  PubMed  Google Scholar 

Mayo S, Messner H, Rourke S, et al. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplant. 2016;51(6):841.

Article  CAS  PubMed  Google Scholar 

Hoogland AI, Nelson AM, Small BJ, et al. The role of age in neurocognitive functioning among adult allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2017;23(11):1974–9.

Article  PubMed  PubMed Central  Google Scholar 

Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013;119(23):4188–95.

Article  PubMed  Google Scholar 

Meadows M-E, Chang G, Jones JA, Antin JR, Orav EJ. Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome. Arch Clin Neuropsychol. 2013;28(4):363–74.

Article  PubMed  PubMed Central  Google Scholar 

Scherwath A, Schirmer L, Kruse M, et al. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology. 2013;22(7):1509–16.

Article  PubMed  Google Scholar 

Sharafeldin N, Bosworth A, Patel SK, et al. Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study. J Clin Oncol. 2017:JCO. 2017.74. 2270.

Dale W, Klepin HD, Williams GR, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO Guideline Update. J Clin Oncol: Official J Am Soc Clin Oncol. 2023;41(26):4293–312. https://doi.org/10.1200/jco.23.00933.

Article  Google Scholar 

Koll TT, Sheese AN, Semin J, et al. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal cognitive assessment and neuropsychological testing. J Geriatric Oncol. 2020;11(2):297–303. https://doi.org/10.1016/j.jgo.2019.11.007.

Article  Google Scholar 

Lew MV, Ren Y, Lowder YP, et al. Geriatric assessment reveals actionable impairments in hematopoietic stem cell transplantation candidates age 18 to 80 years. Transplant Cell Ther. 2022;28(8):498.e1-498.e9. https://doi.org/10.1016/j.jtct.2022.05.018.

Article  PubMed  Google Scholar 

Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.

Article  PubMed  Google Scholar 

Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology. 2011;77(13):1272–5. https://doi.org/10.1212/WNL.0b013e318230208a.

Article  PubMed  Google Scholar 

Carson N, Leach L, Murphy KJ. A re-examination of Montreal COGNITIVE ASSESSMENT (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379–88. https://doi.org/10.1002/gps.4756.

Article  PubMed  Google Scholar 

McDowell LJ, Ringash J, Xu W, et al. A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. Radiother Oncol. 2019;131:179–85. https://doi.org/10.1016/j.radonc.2018.09.012.

Article  PubMed  Google Scholar 

Islam N, Hashem R, Gad M, et al. Accuracy of the Montreal cognitive assessment tool for detecting mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Dement. 2023;19(7):3235–43. https://doi.org/10.1002/alz.13040.

Article  PubMed  Google Scholar 

Costa AS, Fimm B, Friesen P, et al. Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dement Geriatr Cogn Disord. 2012;33(6):379–84. https://doi.org/10.1159/000340006.

Article  PubMed  Google Scholar 

Lindvall E, Abzhandadze T, Quinn TJ, Sunnerhagen KS, Lundstrom E. Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal cognitive assessment. Cereb Circ Cogn Behav. 2024;6:100222. https://doi.org/10.1016/j.cccb.2024.100222.

Article  PubMed  PubMed Central  Google Scholar 

Wong GKC, Mak JSY, Wong A, et al. Minimum clinically important difference of Montreal cognitive assessment in aneurysmal subarachnoid hemorrhage patients. J Clin Neurosci. 2017;46:41–4. https://doi.org/10.1016/j.jocn.2017.08.039.

Article  PubMed  Google Scholar 

Fillenbaum GG, Pieper CF, Cohen HJ, Cornoni-Huntley JC, Guralnik JM. Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol A Biol Sci Med Sci. 2000;55(2):M84–9.

Article  CAS  PubMed  Google Scholar 

Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist. 1969;9(3_Part_1):179–186.

Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94. https://doi.org/10.1093/geronj/49.2.m85.

Article  CAS  PubMed  Google Scholar 

Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.

Article  PubMed  Google Scholar 

Kroenke K, Spitzer RL, Williams JB, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry Jul-Aug. 2010;32(4):345–59. https://doi.org/10.1016/j.genhosppsych.2010.03.006.

Article  Google Scholar 

Karnofsky D, Burchenal J. The evaluation of chemotherapeutic agents against neoplastic disease. Amer Assoc Cancer Research Po Box 11806, Birmingham, AL 35202; 1948:388–389.

Park S-S, Kim H-J, Kim TY, et al. Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study. Blood Res. 2021;56(3):184–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armand P, Kim HT, Logan BR, et al. Validation and refinement of the disease risk index for allogeneic stem cell transplantation. Blood, J Am Soc Hematol. 2014;123(23):3664–71.

CAS  Google Scholar 

Nakamura ZM, Deal AM, Rosenstein DL, et al. Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation. Support Care Cancer : Official J Multinatl Assoc Support Care Cancer. 2021;29(4):2007–14. https://doi.org/10.1007/s00520-020-05697-2.

Article  Google Scholar 

Root JC, Campbell C, Rocha-Cadman X, et al. Pretransplantation cognitive dysfunction in advanced-age hematologic cancers: predictors and associated outcomes. Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant. 2020;26(8):1497–504. https://doi.org/10.1016/j.bbmt.2020.05.010.

Article  Google Scholar 

Smith PJ, Lew M, Lowder Y, et al. Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2022;57(1):89–94.